Search Results - "Foster, Julie"

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group by Irwin, Meredith S, Naranjo, Arlene, Zhang, Fan F, Cohn, Susan L, London, Wendy B, Gastier-Foster, Julie M, Ramirez, Nilsa C, Pfau, Ruthann, Reshmi, Shalini, Wagner, Elizabeth, Nuchtern, Jed, Asgharzadeh, Shahab, Shimada, Hiroyuki, Maris, John M, Bagatell, Rochelle, Park, Julie R, Hogarty, Michael D

“…Treatment planning for children with neuroblastoma requires accurate assessment of prognosis. The most recent Children's Oncology Group (COG) risk…”
Get full text

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group by Campbell, Kevin, Gastier‐Foster, Julie M., Mann, Meegan, Naranjo, Arlene H., Ryn, Collin, Bagatell, Rochelle, Matthay, Katherine K., London, Wendy B., Irwin, Meredith S., Shimada, Hiroyuki, Granger, M. Meaghan, Hogarty, Michael D., Park, Julie R., DuBois, Steven G.

“…BACKGROUND High‐level MYCN amplification (MNA) is associated with poor outcome and unfavorable clinical and biological features in patients with neuroblastoma…”
Get full text

Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors by Walz, Amy L., Ooms, Ariadne, Gadd, Samantha, Gerhard, Daniela S., Smith, Malcolm A., Guidry Auvil, Jaime M., Meerzaman, Daoud, Chen, Qing-Rong, Hsu, Chih Hao, Yan, Chunhua, Nguyen, Cu, Hu, Ying, Bowlby, Reanne, Brooks, Denise, Ma, Yussanne, Mungall, Andrew J., Moore, Richard A., Schein, Jacqueline, Marra, Marco A., Huff, Vicki, Dome, Jeffrey S., Chi, Yueh-Yun, Mullighan, Charles G., Ma, Jing, Wheeler, David A., Hampton, Oliver A., Jafari, Nadereh, Ross, Nicole, Gastier-Foster, Julie M., Perlman, Elizabeth J.

“…We report the most common single-nucleotide substitution/deletion mutations in favorable histology Wilms tumors (FHWTs) to occur within SIX1/2 (7% of 534…”
Get full text

Evidence-based path to newborn screening for duchenne muscular dystrophy by Mendell, Jerry R., Shilling, Chris, Leslie, Nancy D., Flanigan, Kevin M., al-Dahhak, Roula, Gastier-Foster, Julie, Kneile, Kelley, Dunn, Diane M., Duval, Brett, Aoyagi, Alexander, Hamil, Cindy, Mahmoud, Maha, Roush, Kandice, Bird, Lauren, Rankin, Chelsea, Lilly, Heather, Street, Natalie, Chandrasekar, Ram, Weiss, Robert B.

“…Objective: Creatine kinase (CK) levels are increased on dried blood spots in newborns related to the birthing process. As a marker for newborn screening, CK in…”
Get full text

PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report by Skapek, Stephen X., Anderson, James, Barr, Frederic G., Bridge, Julia A., Gastier-Foster, Julie M., Parham, David M., Rudzinski, Erin R., Triche, Timothy, Hawkins, Douglas S.

“…Background Rhabdomyosarcoma (RMS) is divided into two major histological subtypes: alveolar (ARMS) and embryonal (ERMS), with most ARMS expressing one of two…”
Get full text

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients by Pulsipher, Michael A., Carlson, Chris, Langholz, Bryan, Wall, Donna A., Schultz, Kirk R., Bunin, Nancy, Kirsch, Ilan, Gastier-Foster, Julie M., Borowitz, Michael, Desmarais, Cindy, Williamson, David, Kalos, Michael, Grupp, Stephan A.

“…Positive detection of minimal residual disease (MRD) by multichannel flow cytometry (MFC) prior to hematopoietic cell transplantation (HCT) of patients with…”
Get full text

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232 by Borowitz, Michael J., Wood, Brent L., Devidas, Meenakshi, Loh, Mignon L., Raetz, Elizabeth A., Salzer, Wanda L., Nachman, James B., Carroll, Andrew J., Heerema, Nyla A., Gastier-Foster, Julie M., Willman, Cheryl L., Dai, Yunfeng, Winick, Naomi J., Hunger, Stephen P., Carroll, William L., Larsen, Eric

“…Minimal residual disease (MRD) is highly prognostic in pediatric B-precursor acute lymphoblastic leukemia (B-ALL). In Children's Oncology Group high-risk B-ALL…”
Get full text

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia by Dunsmore, Kimberly P, Winter, Stuart S, Devidas, Meenakshi, Wood, Brent L, Esiashvili, Natia, Chen, Zhiguo, Eisenberg, Nancy, Briegel, Nikki, Hayashi, Robert J, Gastier-Foster, Julie M, Carroll, Andrew J, Heerema, Nyla A, Asselin, Barbara L, Rabin, Karen R, Zweidler-Mckay, Patrick A, Raetz, Elizabeth A, Loh, Mignon L, Schultz, Kirk R, Winick, Naomi J, Carroll, William L, Hunger, Stephen P

“…Nelarabine is effective in inducing remission in patients with relapsed and refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully…”
Get full text

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor by Gadd, Samantha, Huff, Vicki, Walz, Amy L, Ooms, Ariadne H A G, Armstrong, Amy E, Gerhard, Daniela S, Smith, Malcolm A, Auvil, Jaime M Guidry, Meerzaman, Daoud, Chen, Qing-Rong, Hsu, Chih Hao, Yan, Chunhua, Nguyen, Cu, Hu, Ying, Hermida, Leandro C, Davidsen, Tanja, Gesuwan, Patee, Ma, Yussanne, Zong, Zusheng, Mungall, Andrew J, Moore, Richard A, Marra, Marco A, Dome, Jeffrey S, Mullighan, Charles G, Ma, Jing, Wheeler, David A, Hampton, Oliver A, Ross, Nicole, Gastier-Foster, Julie M, Arold, Stefan T, Perlman, Elizabeth J

“…Elizabeth Perlman and colleagues use genome-wide sequencing, RNA expression, DNA copy number and methylation analyses to characterize the genomic landscape of…”
Get full text

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group by Reshmi, Shalini C., Harvey, Richard C., Roberts, Kathryn G., Stonerock, Eileen, Smith, Amy, Jenkins, Heather, Chen, I-Ming, Valentine, Marc, Liu, Yu, Li, Yongjin, Shao, Ying, Easton, John, Payne-Turner, Debbie, Gu, Zhaohui, Tran, Thai Hoa, Nguyen, Jonathan V., Devidas, Meenakshi, Dai, Yunfeng, Heerema, Nyla A., Carroll, Andrew J., Raetz, Elizabeth A., Borowitz, Michael J., Wood, Brent L., Angiolillo, Anne L., Burke, Michael J., Salzer, Wanda L., Zweidler-McKay, Patrick A., Rabin, Karen R., Carroll, William L., Zhang, Jinghui, Loh, Mignon L., Mullighan, Charles G., Willman, Cheryl L., Gastier-Foster, Julie M., Hunger, Stephen P.

“…Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk subtype characterized by genomic alterations that activate cytokine…”
Get full text

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232 by Larsen, Eric C, Devidas, Meenakshi, Chen, Si, Salzer, Wanda L, Raetz, Elizabeth A, Loh, Mignon L, Mattano, Jr, Leonard A, Cole, Catherine, Eicher, Alisa, Haugan, Maureen, Sorenson, Mark, Heerema, Nyla A, Carroll, Andrew A, Gastier-Foster, Julie M, Borowitz, Michael J, Wood, Brent L, Willman, Cheryl L, Winick, Naomi J, Hunger, Stephen P, Carroll, William L

“…Survival for children and young adults with high-risk B-acute lymphoblastic leukemia has improved significantly, but 20% to 25% of patients are not cured…”
Get full text

Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study by Moriyama, Takaya, MD, Metzger, Monika L, MD, Wu, Gang, PhD, Nishii, Rina, MS, Qian, Maoxiang, PhD, Devidas, Meenakshi, PhD, Yang, Wenjian, PhD, Cheng, Cheng, Prof, Cao, Xueyuan, PhD, Quinn, Emily, MS, Raimondi, Susana, Prof, Gastier-Foster, Julie M, Prof, Raetz, Elizabeth, Prof, Larsen, Eric, MD, Martin, Paul L, MD, Bowman, W Paul, MD, Winick, Naomi, Prof, Komada, Yoshihiro, Prof, Wang, Shuoguo, PhD, Edmonson, Michael, BA, Xu, Heng, PhD, Mardis, Elaine, Prof, Fulton, Robert, MS, Pui, Ching-Hon, Prof, Mullighan, Charles, Prof, Evans, William E, Prof, Zhang, Jinghui, Prof, Hunger, Stephen P, Prof, Relling, Mary V, Prof, Nichols, Kim E, Prof, Loh, Mignon L, Prof, Yang, Jun J, Dr

“…Summary Background Hereditary predisposition is rarely suspected for childhood acute lymphoblastic leukaemia (ALL). Recent reports of germline ETV6 variations…”
Get full text

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization by Winter, Stuart S, Dunsmore, Kimberly P, Devidas, Meenakshi, Wood, Brent L, Esiashvili, Natia, Chen, Zhiguo, Eisenberg, Nancy, Briegel, Nikki, Hayashi, Robert J, Gastier-Foster, Julie M, Carroll, Andrew J, Heerema, Nyla A, Asselin, Barbara L, Gaynon, Paul S, Borowitz, Michael J, Loh, Mignon L, Rabin, Karen R, Raetz, Elizabeth A, Zweidler-Mckay, Patrick A, Winick, Naomi J, Carroll, William L, Hunger, Stephen P

“…Early intensification with methotrexate (MTX) is a key component of acute lymphoblastic leukemia (ALL) therapy. Two different approaches to MTX intensification…”
Get full text

Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331 by Maloney, Kelly W, Devidas, Meenakshi, Wang, Cindy, Mattano, Leonard A, Friedmann, Alison M, Buckley, Patrick, Borowitz, Michael J, Carroll, Andrew J, Gastier-Foster, Julie M, Heerema, Nyla A, Kadan-Lottick, Nina, Loh, Mignon L, Matloub, Yousif H, Marshall, David T, Stork, Linda C, Raetz, Elizabeth A, Wood, Brent, Hunger, Stephen P, Carroll, William L, Winick, Naomi J

“…Children's Oncology Group (COG) AALL0331 tested whether intensified postinduction therapy that improves survival in children with high-risk B-cell acute…”
Get full text

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells by Emami-Shahri, Nia, Foster, Julie, Kashani, Roxana, Gazinska, Patrycja, Cook, Celia, Sosabowski, Jane, Maher, John, Papa, Sophie

“…The unprecedented efficacy of chimeric antigen receptor (CAR) T-cell immunotherapy of CD19 + B-cell malignancy has established a new therapeutic pillar of…”
Get full text

Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia by Oshima, Koichi, Khiabanian, Hossein, da Silva-Almeida, Ana C., Tzoneva, Gannie, Abate, Francesco, Ambesi-Impiombato, Alberto, Sanchez-Martin, Marta, Carpenter, Zachary, Penson, Alex, Perez-Garcia, Arianne, Eckert, Cornelia, Nicolas, Concepción, Balbin, Milagros, Sulis, Maria Luisa, Kato, Motohiro, Koh, Katsuyoshi, Paganin, Maddalena, Basso, Giuseppe, Gastier-Foster, Julie M., Devidas, Meenakshi, Loh, Mignon L., Kirschner-Schwabe, Renate, Palomero, Teresa, Rabadan, Raul, Ferrando, Adolfo A.

“…Although multiagent combination chemotherapy is curative in a significant fraction of childhood acute lymphoblastic leukemia (ALL) patients, 20% of cases…”
Get full text

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622 by Slayton, William B, Schultz, Kirk R, Kairalla, John A, Devidas, Meenakshi, Mi, Xinlei, Pulsipher, Michael A, Chang, Bill H, Mullighan, Charles, Iacobucci, Ilaria, Silverman, Lewis B, Borowitz, Michael J, Carroll, Andrew J, Heerema, Nyla A, Gastier-Foster, Julie M, Wood, Brent L, Mizrahy, Sherri L, Merchant, Thomas, Brown, Valerie I, Sieger, Lance, Siegel, Marilyn J, Raetz, Elizabeth A, Winick, Naomi J, Loh, Mignon L, Carroll, William L, Hunger, Stephen P

“…Purpose Addition of imatinib to intensive chemotherapy improved survival for children and young adults with Philadelphia chromosome-positive acute…”
Get full text

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children by Qian, Maoxiang, Cao, Xueyuan, Devidas, Meenakshi, Yang, Wenjian, Cheng, Cheng, Dai, Yunfeng, Carroll, Andrew, Heerema, Nyla A, Zhang, Hui, Moriyama, Takaya, Gastier-Foster, Julie M, Xu, Heng, Raetz, Elizabeth, Larsen, Eric, Winick, Naomi, Bowman, W Paul, Martin, Paul L, Mardis, Elaine R, Fulton, Robert, Zambetti, Gerard, Borowitz, Michael, Wood, Brent, Nichols, Kim E, Carroll, William L, Pui, Ching-Hon, Mullighan, Charles G, Evans, William E, Hunger, Stephen P, Relling, Mary V, Loh, Mignon L, Yang, Jun J

“…Purpose Germline TP53 variation is the genetic basis of Li-Fraumeni syndrome, a highly penetrant cancer predisposition condition. Recent reports of germline…”
Get full text

Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group by Rudzinski, Erin R., Anderson, James R., Chi, Yueh‐Yun, Gastier‐Foster, Julie M., Astbury, Caroline, Barr, Frederic G., Skapek, Stephen X., Hawkins, Douglas S., Weigel, Brenda J., Pappo, Alberto, Meyer, William H., Arnold, Michael A., Teot, Lisa A., Parham, David M.

“…Background Distinguishing alveolar rhabdomyosarcoma (ARMS) from embryonal rhabdomyosarcoma (ERMS) has historically been of prognostic and therapeutic…”
Get full text

Isolated late testicular relapse of B‐cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response‐based testicular radiation: A Children's Oncology Group study by Barredo, Julio C., Hastings, Caroline, Lu, Xiamin, Devidas, Meenakshi, Chen, Yichen, Armstrong, Daniel, Winick, Naomi, Wood, Brent Lee, Yanofsky, Rochelle, Loh, Mignon, Gastier‐Foster, Julie M., Jorstad, Dean Thomas, Marcus, Robert, Ritchey, Kim, Carrol, William L., Hunger, Stephen P.

“…Background The incidence of isolated testicular relapse (ITR) of acute lymphoblastic leukemia (ALL) has decreased with contemporary treatment strategies, but…”
Get full text